Acute lymphoblastic leukaemia: open trials in Japan

9 open trials have a site in Japan. Registry data; only the trial team decides who can take part.

NCT07570173
A Clinical Trial of MK-1045 in People With B-cell Acute Lymphoblastic Leukemia (MK-1045-005)
Trial Treatment · Phase 2/3 · Merck Sharp & Dohme LLC
Tokyo Metropolitan Komagome Hospital (Site 2106), Bunkyo · Toranomon Hospital (Site 2101), Minato
Registry updated 2026-10-30
NCT07155226
Study of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants With Advanced Haematologic Malignancies With KMT2Ar, NPM1m, or Other Genotypes Associated With HOX Overexpression
Trial Treatment · Phase 1/2 · AstraZeneca
Bunkyō City · Kashiwa · Okayama
Registry updated 2026-10-23
NCT05327894
Interfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phenotype Acute Leukemia
Trial Treatment · Phase 3 · Princess Maxima Center for Pediatric Oncology
Chiba University Hospital, Chiba · Ehime University Hospital, Ehime · Hiroshima University Hospital, Hiroshima · Hokkaido University Hospital, Hokkaido · Hyogo Prefectural Kobe Childrens Hospital, Hyōgo · Kagoshima University Hospital, Kagoshima · Kanagawa Childrens Medical Center, Kanagawa · Kyoto Prefectural University of Medicine, Kyoto · Kyoto University Hospital, Kyoto · Mie University Hospital, Mie · Nagoya University Graduate School of Medicine, Nagoya · Osaka University Graduate School of Medicine 2-2, Osaka · Osaka City General Hospital, Osaka · Saitama Prefectural Childrens Medical Center, Saitama · Shizuoka Childrens Hospital, Shizuoka · Tohoku University Hospital, Tōhoku · National Center for Child Health and Development, Tokyo · The University of Tokyo Hospital, Tokyo · Nippon Medical School Hospital, Tokyo · Tokyo Metropolitan Childre's Medical Center, Tokyo
Registry updated 2026-10-19
NCT07109219
Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Acute Lymphoblastic Leukemia
Trial Treatment · Phase 1/2 · AstraZeneca
Bunkyō City · Chūōku · Kashiwa
Registry updated 2026-10-15
NCT06137118
AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia
Trial Treatment · Phase 1/2 · AstraZeneca
Bunkyō City · Chiba · Chūōku · Fukuoka · Kashiwa · Kyoto · Okayama · Osaka · Sapporo · Toyohashi · Yamagata
Registry updated 2026-10-13
NCT04094311
Study of Out of Specification for Tisagenlecleucel
Trial Treatment · Phase 3 · Novartis Pharmaceuticals
Aomori · Bunkyo Ku · Chiba · Chuo Ku · Fuchū · Fukuoka · Gifu · Hamamatsu · Hiroshima · Ishikawa · Izumi · Izumisano · Izumo · Kita-gun · Kobe · Kumamoto · Kurashiki · Kyoto · Matsumoto · Minato Ku · Nagasaki · Nagoya · Niigata · Nishinomiya · Okayama · Osaka · Saitama · Sakai · Sapporo · Sendai · Setagaya-ku · Shinjuku Ku · Suita · Tōon · Tsu · Tsukuba · Wakayama · Yokohama · Yufu
Registry updated 2026-09-15
NCT04877522
Asciminib Roll-over Study
Trial Treatment · Phase 4 · Novartis Pharmaceuticals
Kobe
Registry updated 2026-07-06
NCT07075328
A Phase I/II Study of OJP-001 in Patients With Adult T-cell Leukemia/Lymphoma
Trial Treatment · Phase 1/2 · Otsuka Medical Devices Co., Ltd. Japan
National Kyushu Cancer Center, Fukuoka · Imamura General Hospital, Kagoshima · University of Miyazaki Hospital, Miyazaki · Nagasaki University Hospital, Nagasaki · Sapporo Hokuyu Hospital, Sapporo
Registry updated 2026-04-29
NCT04988555
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
Trial Treatment · Phase 1/2 · Sumitomo Pharma America, Inc.
Tokyo Metropolitan Komagome Hospital, Bunkyō City · Nippon Medical School Hospital, Bunkyo-ku · Kyushu University Hospital, Fukuoka · Fukushima Medical University Hospital, Fukushima · Hokkaido University Hospital, Hokkaido · Tokai University Hospital, Isehara-Shi · National Cancer Center Hospital East, Kashiwa-shi · Tohoku University Hospital, Miyagi · Nagasaki University Hospital, Nagasaki · Okayama University Hospital, Okayama · Osaka University Hospital, Osaka · University of Fukui Hospital, Yoshida-gun
Registry updated 2026-03-24

All Acute lymphoblastic leukaemia trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error